期刊文献+

内乳前哨淋巴结显像中的^(99m)T_C-硫胶体标记时间、性状与显影效能 被引量:4

The study of ^(99m)T_C-sulphur colloidal particles’ properties and internal mammary sentinel nodes lymphoscintigraphy
下载PDF
导出
摘要 背景与目的:放射性核素内乳前哨淋巴结(IMSN)显像可引导术中γ探测、摘取IMSN进行活检,由确切的病理学证据指导术后放疗,但用腋窝前哨淋巴结显像的方法观察,则IMSN的显像率很低。本研究旨在探讨改变示踪剂99mTC-硫胶体(SC)的标记时间、分析其性状,以提高IMSN的显像率。方法:将99mTC-SC标记过程中的煮沸时间由说明书要求的3~5min缩短为2min,用透射电子显微镜(TEM)观察胶体颗粒的直径、分布和稳定性,然后进行IMSN显像。结果:新标记条件下胶体颗粒的形态、分布在3h内基本保持稳定,90%的胶粒直径为10nm;之后颗粒逐渐聚合、沉积,4h后直径大于100nm。标记后3h内新鲜使用情况下,IMSN显示清晰。结论:新条件下制备的9mTC-SC在标记后3h内,胶粒性状能满足进入深部毛细淋巴管的要求,使内乳前哨淋巴结显影。 Background and purpose: Internal mammary sentinel nodes (IMSNs) lymphoscintigraphy could guide in y-detecting and removing the IMSNs for the purpose of biopsy during the operation,which is helpful to determine the necessity of postoperative radiotherapy. However,IMSNs imaging rate remains low if using axillary lymph nodes (ALNs) lymphoscintigraphy. This study was to investigate the tracer's properties and try to improve the IMSNs imaging rate through changing the label procedure. Methods: The boiling time of ^99mTc-sulphur colloidal particles was shortened from 3-5 minutes to 2 minutes during the label procedure, then the colloidal particles' diameter, 'distribution and stability were observed by Transmission Electron Microscope (TEM), then the IMSNs lymphoscintigraphy was performed. Results: This colloidal tracer's shape and distribution remained stable for 3 hours, and 90% of the particles had a diameter of 10 nm, the particles tended to aggregate afterwards. 4 hours after labeling, the diameter of particles exceeded 100 nm. IMSNs could be clearly imaged if the tracer was freshly used (within 3, hours after labeling). Conclusion: Within 3 hours after the labeling the unfiltered colloidal tracer with modified procedure, the particle could be used and internal mammary lymph nodes could be imaged more clearly.
作者 周敏 章英剑
出处 《中国癌症杂志》 CAS CSCD 2008年第8期600-603,共4页 China Oncology
关键词 ^99mTc-硫胶体 标记条件 硫胶体性状 透射电子显微镜 内乳前哨淋巴结显像 ^99mTc-sulphur colloid label procedure colloidal properties TEM IMSNs lymphoscintigraphy
  • 相关文献

参考文献4

二级参考文献140

  • 1Glass EC, Essner R, Giuliano AE. Sentinel node localization in breast cancer. Semin in Nucl Med, 1999, 29: 57-68.
  • 2Krag D, Weaver D, Askikaga T, et al. The sentinel node in breast cancer multicentre validation study. N Engl J Med, 1998, 339: 941-946.
  • 3Veronesi U, Paganelli G, Galimberti V, et al. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes, lancet, 1997, 349: 1864-1867.
  • 4Gulec SA, Moffat FL, Carroll RG, et al. Sentinel lymph node localization in early breast cancer. J Nucl Med, 1998, 39: 1388-1393.
  • 5Schmidt MS,Gardner PM,Redlich PN,et al. Breast lymphoscintigraphy:high-volume injection technique improves sentinel lymph node visualization. J Nud Med, 1998, 39: 25P.
  • 6Imoto S, Hasebe T. Initial experience with sentinel node biopsy in breast cancer at the National Cancer Hospital East. Jpn Clin Oncol, 1999, 29:11-15.
  • 7Waddington WA, Keshtgar MR, Taylor I, et al. Radiation safety of the sentinel lymph node technique in breast cancer. Eur J Nud Med, 2000,27: 377-391.
  • 8Uren RF, Howrman-Giles RB, Thompson JF, et al. Mammary lymphoscintigraphy in breast cancer. J Nucl Med, 1995, 38: 1775-1780.
  • 9Bellon JR, Byrd DR, Dunnwald LK. FDG PET and lymphoscintigraphy:towards a comprehensive evaluation of the internal mammary lymph nodes(Abstract). Breast Cancer Res Treat, 2000, 64: 30.
  • 10Abdelhamid Sayari,Microporous Mater,1997年,12卷,149页

共引文献52

同被引文献38

  • 1Bines S, Kopkash K, All A, et al . The use of radioisotope combined with isosulfan blue dye is not superior to radioisotope alone for the identification of sentinel lymph nodes in patients with breast cancer. Surgery, 2008, 144: 606-609.
  • 2Thevarajah S, Huston TL, Simmons RM. A comparison of the adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer. Am J Surg, 2005, 189 : 236-239.
  • 3Mathelin C, Salvador S, Bekaert V, et al. A new intraoperative gamma camera for the sentinel lymph node procedure in breast cancer. Anticancer Res, 2008, 28 (5 B) : 2859-2864.
  • 4Lynch MA, Jackson J, Kim JA, el al. Optimal number of radioaetive sentinel lymph nodes to remove for accurate axillary staging of breast eancer. Surgery, 2008, 144: 525-531.
  • 5Yi M, Meric-Bernstam F, Ross MI, et al. How many sentinel lymph nodes are enough during sentinel lymph node dissection for breast cancer? Cancer, 2008, 113 : 30-37.
  • 6Govindarajan A, Baxter NN. I.ymph node evaluation in early-stage colon cancer. Clin Colorectal Cancer, 2008, 7: 240-246.
  • 7Ansari B, Ogston SA, Purdie CA,et al. Meta-analysis of sentinel node biopsy in ductal carcinoma in situ of the breast. Br J Surg, 2008, 95: 547-554.
  • 8Holwitt DM, Gillanders WE, Aft RL, et al. Sentinel lymph node biopsy in patients with multieentric/multifoeal breast cancer: low false-negalive rate and lack of axillary recurrence. Am J Surg, 2008, 196: 562-565.
  • 9Tausch C, Konstantiniuk P, Kugler F, et al. Sentinel lymph node biopsy after preoperative chemotherapy for breast cancer: findings from the Austrian Sentinel Node Study Group. Ann Surg Oncol, 2008, 15: 3378-3383.
  • 10李涛,郑爱文,谢尚闹,杨红健,肖必文,孟旭莉.γ探测仪结合核素淋巴显像在皮肤恶性黑色素瘤前哨淋巴结检测中的应用[J].中华肿瘤防治杂志,2007,14(20):1583-1584. 被引量:3

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部